Summary List Placement
Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:
- Research suggest people who’ve already had COVID-19 only need one shot;
- What you can and can’t do once vaccinated;
- Alloy joins a wave of biotech startups that are doing more than just developing one drug.
- A single shot of Pfizer or Moderna’s vaccine yields high protection for people who’ve had COVID-19.
- That’s probably because their bodies are responding to a viral threat they’ve seen before.
- One expert said giving people who’ve had COVID-19 a second dose was “kind of a wasted shot.”
- The CDC’s guidelines for vaccinated people don’t cover every scenario, including some common ones.
- There isn’t advice for people who’ve had one dose or for families with members that aren’t immunized.
- Experts weigh in on what’s safe in 6 common scenarios not mentioned in the CDC recommendations.
- Alloy Therapeutics raised a Series C round at a $563 million valuation.
- Alloy licenses scientific tools like “humanized mice,” but also plans to launch its own spinoff companies.
- It’s part of a larger trend in the biotech industry to create startups with multiple business arms.
More stories we’re reading:
- Fauci: The US might not need AstraZeneca’s vaccine (Reuters)
- CDC says fully vaccinated people can safely travel in the US (Insider)
- Companies are trying to bring virtual mental healthcare to kids and teens (Stat News)
- JOIN US APRIL 29: How to invest in the spread of US marijuana legalization (Insider)
- Doctors are accusing UnitedHealthcare of squeezing them like a “boa constrictor” (The New York Times)
- Over 100 million people in the US have received at least one dose of a COVID-19 vaccine (Insider)
Originally published at https://www.businessinsider.com/insiders-top-healthcare-stories-for-april-5-2021-4 on .